Protocol for immunofluorescence detection and quantification of phosphorylated SMAD proteins in human blastocysts

Todd Fallesen1, A Sophie Brumm2

  • 1Crick Advanced Light Microscopy, The Francis Crick Institute, London, UK.

STAR Protocols
|May 29, 2025
PubMed

Insights

This study details a protocol for detecting phosphorylated SMAD proteins in human embryos to understand transforming growth factor β (TGF-β) signaling. The method allows quantification of signaling activity during early development.

Area of Science:

  • Developmental Biology
  • Cell Signaling
  • Molecular Biology

Background:

  • Transforming growth factor β (TGF-β) signaling is crucial for embryonic development.
  • Key pathways include NODAL and bone morphogenetic protein (BMP) signaling.
  • These pathways involve the phosphorylation of SMAD proteins.

Purpose of the Study:

  • To present a protocol for immunofluorescence detection of phosphorylated SMAD proteins in human embryos.
  • To enable combined detection with other transcription factors.
  • To quantify TGF-β superfamily signaling activity in pre-implantation embryos.

Main Methods:

  • Immunofluorescence detection of phosphorylated SMAD proteins.
  • Segmentation of nuclei in human blastocysts.
  • Quantification of immunofluorescence intensity.
  • Combined detection with transcription factors.

Main Results:

  • A detailed protocol for analyzing TGF-β signaling in human embryos is provided.
  • The method allows for nuclear segmentation and intensity quantification.
  • This technique facilitates the study of signaling pathways in early development.

Conclusions:

  • The developed protocol enables robust analysis of TGF-β superfamily signaling in human pre-implantation embryos.
  • This method can be adapted for other mammalian embryos and in vitro models.
  • It provides a valuable tool for investigating developmental signaling events.

Related Concept Videos